1990 - 2021年亚洲及其国家慢性阻塞性肺疾病负担和危险因素:基于2021年全球疾病负担研究的系统分析

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-09-19 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1641719
Zeyuan Wu, Xin Zhang, Pingxi Zhang, Yaling He, Yalin Ye, Yun Pan, Yan Li
{"title":"1990 - 2021年亚洲及其国家慢性阻塞性肺疾病负担和危险因素:基于2021年全球疾病负担研究的系统分析","authors":"Zeyuan Wu, Xin Zhang, Pingxi Zhang, Yaling He, Yalin Ye, Yun Pan, Yan Li","doi":"10.3389/fmed.2025.1641719","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by airflow limitation that is not fully reversible. In Asia, risk exposures such as smoking and ambient PM₂.₅ are prevalent, and regional differences are significant. This has led to the COPD disease burden in this region being at a relatively high level globally. Based on this, this study conducts a systematic assessment of the COPD disease burden in Asia.</p><p><strong>Methods: </strong>Data on incidence, mortality, and disability-adjusted life years (DALYs) were obtained from the Global Burden of Disease (GBD) 2021 study. The analysis incorporated the Sociodemographic Index (SDI) and included stratification by sex and age to reveal the distribution and disparities in the burden of COPD across populations. Joinpoint regression models were used to calculate the annual percent change (APC) and average annual percent change (AAPC) to estimate temporal trends. In addition, major attributable risk factors for COPD were analyzed to identify key drivers of disease burden across regions and populations.</p><p><strong>Results: </strong>In 2021, the number of COPD cases in Asia reached 10,512,843 (95% UI: 9,610,006-11,432,970), with an age-standardized incidence rate of 210.79 per 100,000 persons (95% UI: 193.52-227.94). COPD accounted for 2,885,059 deaths (95% UI: 2,571,267-3,218,689), corresponding to an age-standardized mortality rate of 64.10 per 100,000 persons (95% UI: 56.74-71.66). The total DALYs were 60,507,100 (95% UI: 55,319,463-66,518,282), with an age-standardized rate of 1,253.15 per 100,000 persons (95% UI: 1,148.26-1,376.29). Among Asian subregions, South Asia bore the heaviest burden of COPD. Major risk factors included particulate matter (PM) pollution, smoking, secondhand smoke, and occupational exposure to particulate matter, gases, and fumes (OP-MGF).</p><p><strong>Conclusion: </strong>This study highlights the substantial COPD burden in Asia, with air pollution, smoking, and occupational exposures being the predominant risk factors. Targeted public health interventions are urgently needed to mitigate the COPD burden and improve overall health outcomes in the region.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1641719"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12491052/pdf/","citationCount":"0","resultStr":"{\"title\":\"The burden and risk factors of chronic obstructive pulmonary disease in Asia and its countries from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease study.\",\"authors\":\"Zeyuan Wu, Xin Zhang, Pingxi Zhang, Yaling He, Yalin Ye, Yun Pan, Yan Li\",\"doi\":\"10.3389/fmed.2025.1641719\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by airflow limitation that is not fully reversible. In Asia, risk exposures such as smoking and ambient PM₂.₅ are prevalent, and regional differences are significant. This has led to the COPD disease burden in this region being at a relatively high level globally. Based on this, this study conducts a systematic assessment of the COPD disease burden in Asia.</p><p><strong>Methods: </strong>Data on incidence, mortality, and disability-adjusted life years (DALYs) were obtained from the Global Burden of Disease (GBD) 2021 study. The analysis incorporated the Sociodemographic Index (SDI) and included stratification by sex and age to reveal the distribution and disparities in the burden of COPD across populations. Joinpoint regression models were used to calculate the annual percent change (APC) and average annual percent change (AAPC) to estimate temporal trends. In addition, major attributable risk factors for COPD were analyzed to identify key drivers of disease burden across regions and populations.</p><p><strong>Results: </strong>In 2021, the number of COPD cases in Asia reached 10,512,843 (95% UI: 9,610,006-11,432,970), with an age-standardized incidence rate of 210.79 per 100,000 persons (95% UI: 193.52-227.94). COPD accounted for 2,885,059 deaths (95% UI: 2,571,267-3,218,689), corresponding to an age-standardized mortality rate of 64.10 per 100,000 persons (95% UI: 56.74-71.66). The total DALYs were 60,507,100 (95% UI: 55,319,463-66,518,282), with an age-standardized rate of 1,253.15 per 100,000 persons (95% UI: 1,148.26-1,376.29). Among Asian subregions, South Asia bore the heaviest burden of COPD. Major risk factors included particulate matter (PM) pollution, smoking, secondhand smoke, and occupational exposure to particulate matter, gases, and fumes (OP-MGF).</p><p><strong>Conclusion: </strong>This study highlights the substantial COPD burden in Asia, with air pollution, smoking, and occupational exposures being the predominant risk factors. Targeted public health interventions are urgently needed to mitigate the COPD burden and improve overall health outcomes in the region.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"12 \",\"pages\":\"1641719\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12491052/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2025.1641719\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1641719","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:慢性阻塞性肺疾病(COPD)是一种慢性呼吸系统疾病,其特征是气流受限,且不完全可逆。在亚洲,风险暴露,如吸烟和环境中的PM 2。₅很普遍,区域差异很大。这导致该地区的慢性阻塞性肺病疾病负担在全球处于相对较高的水平。基于此,本研究对亚洲慢阻肺疾病负担进行了系统评估。方法:从全球疾病负担(GBD) 2021研究中获得发病率、死亡率和残疾调整生命年(DALYs)的数据。该分析纳入了社会人口统计指数(SDI),并按性别和年龄分层,以揭示COPD在人群中负担的分布和差异。采用连接点回归模型计算年变化百分比(APC)和平均年变化百分比(AAPC)来估计时间趋势。此外,还分析了COPD的主要归因危险因素,以确定各地区和人群疾病负担的主要驱动因素。结果:2021年,亚洲COPD病例数达到10,512,843例(95% UI: 9,610,006-11,432,970),年龄标准化发病率为每10万人210.79例(95% UI: 193.52-227.94)。慢性阻塞性肺病导致2,885,059人死亡(95%综合死亡率:2,571,267-3,218,689),相当于年龄标准化死亡率为每10万人64.10人(95%综合死亡率:56.74-71.66)。DALYs总数为60,507,100 (95% UI: 55,319,463-66,518,282),年龄标准化率为每10万人1,253.15 (95% UI: 1,148.26-1,376.29)。在亚洲分区域中,南亚的慢性阻塞性肺病负担最重。主要危险因素包括颗粒物(PM)污染、吸烟、二手烟和职业接触颗粒物、气体和烟雾(OP-MGF)。结论:本研究强调了亚洲的慢性阻塞性肺病负担,其中空气污染、吸烟和职业暴露是主要的危险因素。迫切需要有针对性的公共卫生干预措施,以减轻该地区的慢性阻塞性肺病负担并改善总体健康结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The burden and risk factors of chronic obstructive pulmonary disease in Asia and its countries from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease study.

Objective: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by airflow limitation that is not fully reversible. In Asia, risk exposures such as smoking and ambient PM₂.₅ are prevalent, and regional differences are significant. This has led to the COPD disease burden in this region being at a relatively high level globally. Based on this, this study conducts a systematic assessment of the COPD disease burden in Asia.

Methods: Data on incidence, mortality, and disability-adjusted life years (DALYs) were obtained from the Global Burden of Disease (GBD) 2021 study. The analysis incorporated the Sociodemographic Index (SDI) and included stratification by sex and age to reveal the distribution and disparities in the burden of COPD across populations. Joinpoint regression models were used to calculate the annual percent change (APC) and average annual percent change (AAPC) to estimate temporal trends. In addition, major attributable risk factors for COPD were analyzed to identify key drivers of disease burden across regions and populations.

Results: In 2021, the number of COPD cases in Asia reached 10,512,843 (95% UI: 9,610,006-11,432,970), with an age-standardized incidence rate of 210.79 per 100,000 persons (95% UI: 193.52-227.94). COPD accounted for 2,885,059 deaths (95% UI: 2,571,267-3,218,689), corresponding to an age-standardized mortality rate of 64.10 per 100,000 persons (95% UI: 56.74-71.66). The total DALYs were 60,507,100 (95% UI: 55,319,463-66,518,282), with an age-standardized rate of 1,253.15 per 100,000 persons (95% UI: 1,148.26-1,376.29). Among Asian subregions, South Asia bore the heaviest burden of COPD. Major risk factors included particulate matter (PM) pollution, smoking, secondhand smoke, and occupational exposure to particulate matter, gases, and fumes (OP-MGF).

Conclusion: This study highlights the substantial COPD burden in Asia, with air pollution, smoking, and occupational exposures being the predominant risk factors. Targeted public health interventions are urgently needed to mitigate the COPD burden and improve overall health outcomes in the region.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信